{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T13:40:13Z","timestamp":1762782013676},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81201586","31271382"],"award-info":[{"award-number":["81201586","31271382"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["5122020"],"award-info":[{"award-number":["5122020"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011637","name":"State Key Laboratory of Molecular Oncology","doi-asserted-by":"crossref","award":["SKL-KF-2013-03"],"award-info":[{"award-number":["SKL-KF-2013-03"]}],"id":[{"id":"10.13039\/501100011637","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010026","name":"Beijing Higher Education Young Elite Teacher Project","doi-asserted-by":"crossref","award":["YETP0521"],"award-info":[{"award-number":["YETP0521"]}],"id":[{"id":"10.13039\/501100010026","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Program for Changjiang Scholars and Innovative Research Team in University","award":["IRT13045"],"award-info":[{"award-number":["IRT13045"]}]},{"name":"Beijing City Talent Training Project","award":["2012D009016000002"],"award-info":[{"award-number":["2012D009016000002"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Talanta"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.talanta.2016.08.007","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T06:03:00Z","timestamp":1470290580000},"page":"636-644","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Prediction of biomarkers of therapeutic effects of patients with lung adenocarcinoma treated with gefitinib based on progression-free-survival by metabolomic fingerprinting"],"prefix":"10.1016","volume":"160","author":[{"given":"Jingcong","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenxia","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.talanta.2016.08.007_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.27711","article-title":"Global estimates of cancer prevalence for 27 sites in the adult population in 2008","volume":"132","author":"Bray","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.talanta.2016.08.007_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer Statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.talanta.2016.08.007_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.talanta.2016.08.007_bib4","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.apjtb.2016.02.001","article-title":"Unusual presentation of metastatic adenocarcinoma of the lung","volume":"6","author":"Resuli","year":"2016","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"10.1016\/j.talanta.2016.08.007_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.humpath.2016.02.027","article-title":"Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non\u2013small cell lung carcinomas using fine-needle aspiration cases","volume":"54","author":"Sharma","year":"2016","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.talanta.2016.08.007_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.talanta.2016.08.007_bib7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00001622-200403000-00008","article-title":"The role of EGFR inhibitors in non small cell lung cancer","volume":"16","author":"Ciardiello","year":"2004","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.talanta.2016.08.007_bib8","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1200\/JCO.2010.33.4235","article-title":"Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin\/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS)","volume":"29","author":"Fukuoka","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.talanta.2016.08.007_bib9","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1200\/JCO.2005.09.985","article-title":"Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology","volume":"23","author":"J\u00e4nne","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.talanta.2016.08.007_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1470-2045(09)70364-X","article-title":"Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomized phase 3 trial","volume":"11","author":"Mitsudomi","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.talanta.2016.08.007_bib11","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1470-2045(11)70184-X","article-title":"Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study","volume":"12","author":"Zhou","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.talanta.2016.08.007_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.toxlet.2007.05.021","article-title":"The use of metabolomics for the discovery of new biomarkers of effect","volume":"172","author":"van Ravenzwaay","year":"2007","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.talanta.2016.08.007_bib13","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1002\/pmic.200600106","article-title":"Metabolomics: current technologies and future trends","volume":"6","author":"Hollywood","year":"2006","journal-title":"Proteomics"},{"key":"10.1016\/j.talanta.2016.08.007_bib14","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1053\/j.gastro.2014.01.017","article-title":"Biomarkers of coordinate metabolic reprogramming in colorectal tumors in mice and humans","volume":"146","author":"Manna","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.talanta.2016.08.007_bib15","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1158\/1078-0432.CCR-13-1939","article-title":"A distinct metabolic signature of human colorectal cancer with prognostic potential","volume":"20","author":"Qiu","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.talanta.2016.08.007_bib16","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1158\/0008-5472.CAN-13-0308","article-title":"Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics","volume":"73","author":"Huang","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.talanta.2016.08.007_bib17","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1158\/0008-5472.CAN-14-0109","article-title":"Non-invasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer","volume":"74","author":"Math\u00e9","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.talanta.2016.08.007_bib18","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1021\/ac2012224","article-title":"Is serum or plasma more appropriate for intersubject comparisons in metabolomic studies? An assessment in patients with small-cell lung cancer","volume":"83","author":"Wedge","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2016.08.007_bib19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1021\/ac051312t","article-title":"Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry","volume":"78","author":"Want","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2016.08.007_bib20","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/rcm.1627","article-title":"Ultra-performance liquid chromatography coupled to quadrupole-orthogonal time-of-flight mass spectrometry","volume":"18","author":"Plumb","year":"2004","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.talanta.2016.08.007_bib21","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1021\/ac060245f","article-title":"Nonlinear data alignment for UPLC-MS and HPLC-MS based metabolomics: quantitative analysis of endogenous and exogenous metabolites in human serum","volume":"78","author":"Nordstr\u00f6m","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2016.08.007_bib22","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1021\/ac701727r","article-title":"Fully automated four-column capillary LC-MS system for maximizing throughput in proteomic analyses","volume":"80","author":"Livesay","year":"2008","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2016.08.007_bib23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jchromb.2007.10.022","article-title":"LC-MS-based metabonomics analysis","volume":"866","author":"Lu","year":"2008","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.talanta.2016.08.007_bib24","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1021\/ac051495j","article-title":"Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation","volume":"78","author":"Bijlsma","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.talanta.2016.08.007_bib25","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1021\/pr060256p","article-title":"Metabonomics study of intestinal fistulas based on ultraperformance liquid chromatography coupled with Q-TOF mass spectrometry (UPLC\/Q-TOF MS)","volume":"5","author":"Yin","year":"2006","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.talanta.2016.08.007_bib26","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/jssc.200700650","article-title":"Ultra-performance LC\/TOF MS analysis of medicinal Panax herbs for metabolomic research","volume":"31","author":"Xie","year":"2008","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.talanta.2016.08.007_bib27","unstructured":"User\u2019s Guide to SIMCA-P, SIMCA-P+ version 11.0, 2005."},{"key":"10.1016\/j.talanta.2016.08.007_bib28","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.talanta.2016.08.007_bib29","first-page":"27","article-title":"Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro","volume":"13","author":"Medes","year":"1953","journal-title":"Cancer Res."},{"key":"10.1016\/j.talanta.2016.08.007_bib30","first-page":"4169","article-title":"Fatty acid synthase (FAS) is a marker of increased risk of recurrence in lung carcinoma","volume":"24","author":"Visca","year":"2004","journal-title":"Anticancer Res."},{"key":"10.1016\/j.talanta.2016.08.007_bib31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cell.2009.11.027","article-title":"Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis","volume":"140","author":"Nomura","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.talanta.2016.08.007_bib32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1126\/science.1198973","article-title":"Adipose triglyceride lipase contributes to cancer-associated cachexia","volume":"333","author":"Das","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.talanta.2016.08.007_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.mco.0000165004.93707.88","article-title":"Systemic inflammation, cachexia and prognosis in patients with cancer","volume":"8","author":"Deans","year":"2005","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"}],"container-title":["Talanta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914016305781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039914016305781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T02:40:10Z","timestamp":1589683210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039914016305781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":33,"alternative-id":["S0039914016305781"],"URL":"https:\/\/doi.org\/10.1016\/j.talanta.2016.08.007","relation":{},"ISSN":["0039-9140"],"issn-type":[{"value":"0039-9140","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of biomarkers of therapeutic effects of patients with lung adenocarcinoma treated with gefitinib based on progression-free-survival by metabolomic fingerprinting","name":"articletitle","label":"Article Title"},{"value":"Talanta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.talanta.2016.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}